Stockreport

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF The position represents 1.99% of 13F assets under management (AUM). Travere Therapeutics is not among the fund's top five holdings after the trade. These 10 stocks [Read more]